NCT05118152

Brief Summary

Congenital heart disease (CHD) is the leading cause of birth defects, with an incidence of 0.8%. Among CHD, univentricular heart disease or "single ventricle" is rare and complex. As a result of the improved patient care over the last decades, the number of children and adults with single ventricle is increasing significantly. Today, the main challenge is to ensure an optimal follow-up of these new patients in order to improve their life expenctancy as well as their quality of life (QoL). Currently, echocardiography and cardiopulmonary exercice test (CPET) are central in management of patients with single ventricle as part of good clinical practice guidelines. Single ventricle volumes and function are very difficult to asses with conventional echocardiography because of their complex geometry. Indeed, single ventricle size and morphology vary depending on the patient characteristics and on the initial CHD (before surgical repair). That's why conventional 2D echocardiographic parameters are not reliable for single ventricle assessment. Magnetic resonance imaging (MRI) is more effective in assessing single ventricle volumes and function. Nevertheless, MRI is not universally available, is not practical in many situations, is expensive, and is a relative contraindication in patients with pacemakers. Over the past decade, the use of the 3D echocardiography has increased. This is an available tool that can assess ventricular function and volumes in few seconds. Recent studies shown a good correlation between 3D echocardiography and MRI for assessment of ventricular volumes and function in patient with CHD and especially in those with single ventricle. Moreover, according to some authors, CPET parameters are strongly correlated with risk of hospitalization, risk of death, physical activity and quality of life, especially in patients with single ventricle. To date, there is no study performed about the relationship between 3D echocardiography and CPET parameters in patients with single ventricle.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 19, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 11, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

October 27, 2023

Status Verified

October 1, 2023

Enrollment Period

1.1 years

First QC Date

July 19, 2021

Last Update Submit

October 24, 2023

Conditions

Keywords

univentricular heartPaediatric cardiologycardiopulmonary exercise test3D echocardiography

Outcome Measures

Primary Outcomes (1)

  • Association between single ventricle volumes and function parameters in 3D echocardiography

    Association between single ventricle volumes and function parameters in 3D echocardiography (End-diastolic volume, End-systolic volume, Stroke volume)

    day 1

Secondary Outcomes (6)

  • Association between 3D echocardiography and clinical data collected

    day 1

  • Association between 3D echocardiography and quality of life data usually collected

    day 1

  • ssociation between 3D echocardiography and 2D echocardiography data usually collected

    day 1

  • Association between 3D echocardiography and blood test data usually collected.

    day 1

  • Association between 3D echocardiography and MRI data usually collected.

    day 1

  • +1 more secondary outcomes

Eligibility Criteria

Age8 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with a single ventricle or univentricular heart

You may qualify if:

  • Patient over 8 years old with univentricular heart disease as defined by the ACC-CHD classification
  • Agreement from adults or parents if minor patients
  • CPET performed within the 6 months before or after performing echocardiography

You may not qualify if:

  • Cardiomyopathy unrelated to CHD (eg coronary artery disease, toxic cardiomyopathy)
  • Significant clinical status change between performing CPET and performing echocardiography, according to the investigator's opinion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uh Montpellier

Montpellier, 34295, France

Location

Related Publications (1)

  • Femenia V, Pommier V, Huguet H, Iriart X, Picot MC, Bredy C, Lorca L, De La Villeon G, Guillaumont S, Pasquie JL, Matecki S, Roubertie F, Leobon B, Thambo JB, Jalal Z, Thomas J, Mouton JB, Avesani M, Amedro P. Correlation between three-dimensional echocardiography and cardiopulmonary fitness in patients with univentricular heart: A cross-sectional multicentre prospective study. Arch Cardiovasc Dis. 2023 Apr;116(4):202-209. doi: 10.1016/j.acvd.2023.02.002. Epub 2023 Mar 9.

    PMID: 36966111BACKGROUND

MeSH Terms

Conditions

Univentricular HeartHeart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Pascal AMEDRO, MD-PhD

    UH MONTPELLIER

    STUDY DIRECTOR
  • Valentin FEMENIA, resident

    UH MONTPELLIER

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2021

First Posted

November 11, 2021

Study Start

June 1, 2021

Primary Completion

June 30, 2022

Study Completion

June 30, 2022

Last Updated

October 27, 2023

Record last verified: 2023-10

Locations